• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients.

作者信息

Bodey G P, Ketchel S J, Rodriguez V

出版信息

Am J Med. 1979 Oct;67(4):608-16. doi: 10.1016/0002-9343(79)90242-0.

DOI:10.1016/0002-9343(79)90242-0
PMID:495630
Abstract

Patients were randomly assigned to receive carbenicillin plus tobramycin by continuous infusion (C+T), carbenicillin plus cefamandole by continuous infusion (C+CC) or carbenicillin plus cefamandole by intermittent infusion (C+IC) during 490 febrile episodes. Carbenicillin was administered over 2 hours every 4 hours. The per cent of cures achieved during the 235 documented infections was 65 per cent for C+CC, 57 per cent for C+IC and 54 per cent for C+T. Among those infections caused by single gram-negative bacilli, C+CC produced a higher cure rate than C+IC or C+T(74 per cent versus 59 per cent versus 50 per cent). C+CC was significantly more effective than C+IC among patients with persistent severe neutropenia of less than 100 neutrophils/mm3 (65 per cent versus 21 per cent, p = 0.03). If the infecting organism was sensitive to both antibiotics, the cure rate which occurred during 12 per cent to 13 per cent of the febrile episodes, regardless of antibiotic regimen. However, it occurred significantly more often during documented infections than during fevers of unknown etiology (20 per cent versus 6 per cent, p less than 0.001). C+CC appears to be the most effective of the three regimens for the treatment of infections in patients with persistent severe neutropenia.

摘要

相似文献

1
A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients.
Am J Med. 1979 Oct;67(4):608-16. doi: 10.1016/0002-9343(79)90242-0.
2
Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.羧苄青霉素加头孢孟多治疗癌症患者感染
J Infect Dis. 1978 May;137 Suppl:S139-S143. doi: 10.1093/infdis/137.supplement.s139.
3
Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.
Arch Intern Med. 1984 May;144(5):1005-10.
4
Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients.
Am J Med Sci. 1979 May-Jun;277(3):311-8. doi: 10.1097/00000441-197905000-00010.
5
Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
J Infect Dis. 1978 May;137 Suppl:S144-S149. doi: 10.1093/infdis/137.supplement.s144.
6
A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli.
Rev Infect Dis. 1983 Mar-Apr;5 Suppl 1:S173-80. doi: 10.1093/clinids/5.supplement_1.s173.
7
A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.替卡西林加妥布霉素与羧苄西林加庆大霉素治疗革兰氏阴性杆菌所致严重感染的比较研究。
Am J Med. 1978 Jun;64(6):961-6. doi: 10.1016/0002-9343(78)90450-3.
8
Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study.羧苄青霉素-甲氧苄啶/磺胺甲恶唑与羧苄青霉素-庆大霉素作为粒细胞减少患者感染经验性治疗的比较。一项前瞻性、随机、双盲研究。
Am J Med. 1980 Jun;68(6):876-85. doi: 10.1016/0002-9343(80)90217-x.
9
Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients.β-内酰胺类抗生素单独使用或与庆大霉素联合使用,用于治疗中性粒细胞减少患者的革兰氏阴性杆菌感染。
Am J Med Sci. 1976 Mar-Apr;271(2):179-86. doi: 10.1097/00000441-197603000-00006.
10
Comparison of cefamandole and carbenicillin in preventing sepsis following penetrating abdominal trauma.头孢孟多与羧苄西林预防腹部穿透伤后败血症的比较。
Am Surg. 1985 Oct;51(10):580-6.

引用本文的文献

1
Extended infusion of piperacillin-tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study.哌拉西林他唑巴坦持续输注与间断输注治疗危重症埃及患者的成本效果研究。
Sci Rep. 2022 Jun 27;12(1):10882. doi: 10.1038/s41598-022-12861-7.
2
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.随机对照试验中,与β-内酰胺类联合氨基糖苷类相比,双联β-内酰胺类组合疗法治疗革兰氏阴性菌具有相当的疗效和更好的安全性。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00425-19. Print 2019 Jul.
3
Measurement of piperacillin plasma concentrations in cancer patients with suspected infection.
测量疑似感染癌症患者的哌拉西林血浆浓度。
Infection. 2017 Oct;45(5):629-636. doi: 10.1007/s15010-017-1026-z. Epub 2017 May 17.
4
Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.持续和延长静脉内β-内酰胺类药物给药:对临床实验室的影响
Clin Microbiol Rev. 2016 Oct;29(4):759-72. doi: 10.1128/CMR.00022-16.
5
An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.脓毒症和感染性休克的另一种病理生理模式:优化抗菌治疗的意义。
Virulence. 2014 Jan 1;5(1):80-97. doi: 10.4161/viru.26913. Epub 2013 Nov 1.
6
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.持续输注与间歇输注抗生素治疗严重急性感染
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008481. doi: 10.1002/14651858.CD008481.pub2.
7
Continuous infusion of piperacillin/tazobactam in septic critically ill patients--a multicenter propensity matched analysis.脓毒症危重症患者中哌拉西林/他唑巴坦持续输注的多中心倾向匹配分析。
PLoS One. 2012;7(11):e49845. doi: 10.1371/journal.pone.0049845. Epub 2012 Nov 21.
8
Continuous beta-lactam infusion in critically ill patients: the clinical evidence.危重症患者的持续β-内酰胺输注:临床证据。
Ann Intensive Care. 2012 Aug 16;2(1):37. doi: 10.1186/2110-5820-2-37.
9
Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?危重症患者的抗生素持续输注:β-内酰胺类和万古霉素的新圣杯?
Ann Intensive Care. 2012 Jul 2;2(1):22. doi: 10.1186/2110-5820-2-22.
10
Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.β-内酰胺类药物延长输注与间歇性输注相比是否能改善临床结局?一项随机对照试验的荟萃分析和系统评价。
BMC Infect Dis. 2011 Jun 22;11:181. doi: 10.1186/1471-2334-11-181.